| Product Name |
Fulvestrant Inhouse Impurity 19 / (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol |
| Product Category | Impurities, Intermediates |
| Sub-Category | Metabolites, Pharmaceutical Standards, Fine Chemicals |
| CAS No | 153004-31-0 |
| Catalog Number | GS.47.FUL.49 |
| Chemical Name/Synonyms | (7R,8R,9S,13S,14S,17S)-13-Methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-, (7α,17β); (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]estra-1,3,5(10)-triene-3,17-diol; (7α,17β)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol; 7α-[9-(4,4,5,5,5-Pentafluoropentylsulfanyl)nonyl]estra-1,3,5(10)-triene-3,17β-diol; |
| Molecular Weight | 590.77 |
| Molecular Formula | C32H47F5O2S |
| Purity | NLT 95 % |
| Applications | It is an impurity of Fulvestrant which is used to treat Breast Cancer |
| Inventory Status | customized |